AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on creating technologies that expand the utility and improve the safety of cell-based immunotherapy for cancer, is seeking a Director of CMC to oversee and recommend improvements to the company’s manufacturing processes. Working alongside our Chief Operating Officer, you will join a [...]
NATICK, Mass., June 21, 2021 /PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR-T cells against solid cancers, announced today the addition of Matt Britz to its management team as its Senior Vice President of Business Development. "Matt brings deep industry experience, [...]
NATICK, Mass., June 15, 2021 /PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company developing safe, effective ways to use CAR T cells against solid cancers, announced today the addition of Dr. Jim Mulé to its Scientific Advisory Board to provide strategic guidance for its scientific programs. He joins Dr. [...]